Patents Assigned to LIPHA
  • Patent number: 7159012
    Abstract: This computational data processing system comprises an assembly of networked computers (12, . . . 22) in each of which is stored at least one computational application, and a machine (10) for storing computational data which is linked to the network and in communication with the computers, at least one of the computers (12) operating as master computer and at least some of the other computers (14, . . . 22) operating as slave computer. At least one of the computers comprises, stored in memory an algorithm for configuring the other computers of the network as slave computers and an executable master application for managing the tasks of each slave computer (14, . . . 22) as a function of their availability for the assignment, to each of them, of computational tasks and of corresponding computational data which are stored in the storage machine (10).
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: January 2, 2007
    Assignee: LIPHA
    Inventors: Edouard Viollet, Thierry Convard, Jacques Barbanton
  • Patent number: 7034021
    Abstract: The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. Said compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: April 25, 2006
    Assignee: LIPHA
    Inventors: Gérard Moinet, Daniel Cravo, Liliane Doare, Micheline Kergoat, Didier Mesangeau
  • Publication number: 20050165022
    Abstract: The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. The compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
    Type: Application
    Filed: March 22, 2005
    Publication date: July 28, 2005
    Applicant: LIPHA
    Inventors: Gerard Moinet, Daniel Cravo, Liliane Doare, Micheline Kergoat, Didier Mesangeau
  • Patent number: 6512009
    Abstract: A pharmaceutical composition for the treatment of alcohol and drug dependence, comprising a therapeutically effective amount of a combination of: (i) an opioid antagonist; and (ii) a NMDA receptor complex modulator. A pharmaceutical kit is also provided, comprising these two substances. The opioid antagonist can, for example, be naltrexone and the NMDA receptor complex modulator can be a spermidine site modulator such as acamprosate.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: January 28, 2003
    Assignee: Lipha
    Inventors: Martine Daoust, Yves Bonhomme, Philippe Durbin
  • Patent number: 6303146
    Abstract: The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
    Type: Grant
    Filed: July 14, 1999
    Date of Patent: October 16, 2001
    Assignee: LIPHA
    Inventors: Yves Bonhomme, Geoffrey Nicholson, Gillian Cave, Sarah J. Nicholson
  • Publication number: 20010023434
    Abstract: This computational data processing system comprises an assembly of networked computers (12, . . . 22) in each of which is stored at least one computational application, and a machine (10) for storing computational data which is linked to the network and in communication with the computers, at least one of the computers (12) operating as master computer and at least some of the other computers (14, . . . 22) operating as slave computer. At least one of the computers comprises, stored in memory an algorithm for configuring the other computers of the network as slave computers and an executable master application for managing the tasks of each slave computer (14, . . . 22) as a function of their availability for the assignment, to each of them, of computational tasks and of corresponding computational data which are stored in the storage machine (10).
    Type: Application
    Filed: March 15, 2001
    Publication date: September 20, 2001
    Applicant: Lipha
    Inventors: Edouard Viollet, Thierry Convard, Jacques Barbanton
  • Patent number: 6265437
    Abstract: Derivatives of sulphonic aminoalkane acids, corresponding to formula (I) where X is  R1, R2 and R3 are selected from hydrogen and a C1-C7 alkyl radical, and A is a group of the formula (e) where v and w are 0, 1, 2 or a group of formula (f) where R5 and R6 are selected independently of each other from hydrogen, a C1-C7 alkyl radical, an aryl radical having between 6 and 14 carbon atoms and a heteroaryl radical; t is 1-3; R4 is selected from hydrogen, a C1-C7 alkyl radical, a CF3 radical, an aryl radical having between 6 and 14 carbon atoms and a heteroaryl radical; M is a monovalent metal (Na, K, Li) or a divalent metal (Ca, Mg, Sr, Zn); m is 1 or 2; p is 1-2 and q is 1-2; and where p and q are such that the electrical neutrality of the salt is ensured. The compounds can be used for the treatment of alcohol dependence.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: July 24, 2001
    Assignee: LIPHA
    Inventors: Jean-Jacques Berthelon, Philippe Durbin